David L. Snitman

2013

In 2013, David L. Snitman earned a total compensation of $866K as Chief Operating Officer and Vice President, Business Development at Array BioPharma, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,344
Option Awards$286,344
Salary$384,275
Other$32,019
Total$865,982

Snitman received $384.3K in salary, accounting for 44% of the total pay in 2013.

Snitman also received $163.3K in non-equity incentive plan, $286.3K in option awards and $32K in other compensation.

Rankings

In 2013, David L. Snitman's compensation ranked 7,277th out of 12,286 executives tracked by ExecPay. In other words, Snitman earned more than 40.8% of executives.

ClassificationRankingPercentile
All
7,277
out of 12,286
41st
Division
Manufacturing
2,600
out of 4,612
44th
Major group
Chemicals And Allied Products
808
out of 1,466
45th
Industry group
Drugs
606
out of 1,160
48th
Industry
Pharmaceutical Preparations
478
out of 890
46th
Source: SEC filing on September 13, 2013.

Snitman's colleagues

We found seven more compensation records of executives who worked with David L. Snitman at Array BioPharma in 2013.

2013

Ron Squarer

Array BioPharma

Chief Executive Officer

2013

Ron Chief

Array BioPharma

Executive Officer

2013

Andrew Robbins

Array BioPharma

Chief Operating Officer

2013

Michael Needle

Array BioPharma

Chief Medical Officer

2013

Kevin Koch

Array BioPharma

Chief Scientific Officer

2013

R Carruthers

Array BioPharma

Chief Financial Officer

2013

John Moore

Array BioPharma

General Counsel

You may also like